Clinical Trial Update: COMBINE (Acamprosate/Naltrexone) [Phase 3]

View source ↗

Summary

Phase 3 COMBINE trial evaluating the combination of acamprosate and naltrexone for alcohol use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)
• acamprosate (acamprosate)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Alcoholism | Phase 3 | Status: COMPLETED